Intra-Cellular Therapies Inc. (ITCI) Declined -7.39% or -0.96 To Price $12.04 On Friday

Intra-Cellular Therapies Inc. (ITCI) declined -7.39% or -0.96 to $12.04. It is around 284504 shares traded, which is 87.96% compare to the average total volume 323442. The market cap of ITCI is $663.61 million. The year to date change is 5.46%. The 52 week price range is from $10.21 to $23.64. Price of ITCI have changed -3.13% during last week. It have changed -6.94% over last month, 1.01% over last 3 months, -36.59% over last 6 months and -47.94% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ITCI is 12.94. It is 7.48% above current price. The 200-day Moving Averages for ITCI is 17.26. It is 43.36% above current price. The 52-week High is 23.64. It is 96.35% from the current price. The 52-week Low is 10.21. It is -15.20% from current price.

There are some statistics of ITCI. It is has market cap $663.61 million. The share outstanding is 55.12 million. The average volume is 323442. The percent of top 15 Institution holding is 124.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ITCI is -40.18%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ITCI is -37.44%.


Share this post